Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
53
IBIO Quote, Financials, Valuation and Earnings
Last price:
$2.84
Seasonality move
:
-4.23%
Day range:
$2.60 - $2.86
52-week range:
$0.56 - $6.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
420.73x
P/B ratio:
1.73x
Volume:
709.5K
Avg. volume:
1.1M
1-year change:
-52.44%
Market cap:
$97.8M
Revenue:
$400K
EPS (TTM):
-$1.01
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4M | $1.9M | -- | $225K | $400K | |
| Revenue Growth (YoY) | 44.75% | -20.54% | -100% | -- | 77.78% | |
| Cost of Revenues | $1.5M | $3.8M | $1.1M | $1.3M | $1.1M | |
| Gross Profit | $909K | -$1.9M | -$1.1M | -$1M | -$726K | |
| Gross Profit Margin | 38.34% | -101.22% | -- | -455.56% | -181.5% | |
| R&D Expenses | $10M | $9.8M | $10.3M | $5.2M | $8.3M | |
| Selling, General & Admin | $22M | $21.8M | $19M | $11.7M | $10.7M | |
| Other Inc / (Exp) | $10.2M | $7K | -$98K | $1M | -- | |
| Operating Expenses | $32M | $27.8M | $27.7M | $15.6M | $17.9M | |
| Operating Income | -$31.1M | -$29.7M | -$28.8M | -$16.6M | -$18.6M | |
| Net Interest Expenses | $2.3M | $1.4M | $83K | $172K | $212K | |
| EBT. Incl. Unusual Items | -$23.2M | -$29.5M | -$29.3M | -$15.4M | -$18.4M | |
| Earnings of Discontinued Ops. | -- | -$20.8M | -$35.7M | -$9.5M | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$23.2M | -$50.3M | -$65M | -$24.9M | -$18.4M | |
| Minority Interest in Earnings | $6K | -$1K | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$23.2M | -$29.5M | -$29.3M | -$15.4M | -$18.4M | |
| Basic EPS (Cont. Ops) | -$60.00 | -$2,889.06 | -$106.18 | -$6.50 | -$1.75 | |
| Diluted EPS (Cont. Ops) | -$60.00 | -$2,889.06 | -$106.18 | -$6.50 | -$1.75 | |
| Weighted Average Basic Share | $391.3K | $17.4K | $612.2K | $3.8M | $10.5M | |
| Weighted Average Diluted Share | $391.3K | $17.4K | $612.2K | $3.8M | $10.5M | |
| EBITDA | -$18.3M | -$25.9M | -$27.7M | -$15.4M | -$17.5M | |
| EBIT | -$20.8M | -$29.7M | -$28.8M | -$16.6M | -$18.6M | |
| Revenue (Reported) | $2.4M | $1.9M | -- | $225K | $400K | |
| Operating Income (Reported) | -$31.1M | -$29.7M | -$28.8M | -$16.6M | -$18.6M | |
| Operating Income (Adjusted) | -$20.8M | -$29.7M | -$28.8M | -$16.6M | -$18.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $200K | -- | |
| Revenue Growth (YoY) | -100% | -- | -- | -- | -100% | |
| Cost of Revenues | $1M | $299K | $387K | $281K | $241K | |
| Gross Profit | -$1M | -$299K | -$387K | -$81K | -$241K | |
| Gross Profit Margin | -- | -- | -- | -40.5% | -- | |
| R&D Expenses | $1.9M | $2.8M | $1.5M | $1.9M | $4.3M | |
| Selling, General & Admin | $5.4M | $7.8M | $3M | $2.7M | $5.2M | |
| Other Inc / (Exp) | $5K | -- | -- | -- | -- | |
| Operating Expenses | $6.2M | $10.3M | $4.1M | $4.3M | $6.7M | |
| Operating Income | -$7.2M | -$10.6M | -$4.5M | -$4.4M | -$6.9M | |
| Net Interest Expenses | -- | $31K | $34K | $57K | $41K | |
| EBT. Incl. Unusual Items | -$7.2M | -$10.6M | -$4.5M | -$4.4M | -$9M | |
| Earnings of Discontinued Ops. | -$4.7M | -$23M | -$3.7M | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$11.9M | -$33.6M | -$8.2M | -$4.4M | -$9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.2M | -$10.6M | -$4.5M | -$4.4M | -$9M | |
| Basic EPS (Cont. Ops) | -$27.39 | -$68.43 | -$4.42 | -$0.48 | -$0.09 | |
| Diluted EPS (Cont. Ops) | -$27.39 | -$68.43 | -$4.42 | -$0.48 | -$0.09 | |
| Weighted Average Basic Share | $436K | $490.4K | $1.9M | $9.1M | $99.1M | |
| Weighted Average Diluted Share | $436K | $490.4K | $1.9M | $9.1M | $99.1M | |
| EBITDA | -$6.2M | -$10.3M | -$4.1M | -$4.1M | -$6.7M | |
| EBIT | -$7.2M | -$10.6M | -$4.5M | -$4.4M | -$6.9M | |
| Revenue (Reported) | -- | -- | -- | $200K | -- | |
| Operating Income (Reported) | -$7.2M | -$10.6M | -$4.5M | -$4.4M | -$6.9M | |
| Operating Income (Adjusted) | -$7.2M | -$10.6M | -$4.5M | -$4.4M | -$6.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3M | $1.8M | $50K | $375K | $300K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.8M | $2.1M | $950K | $1.2M | $1.1M | |
| Gross Profit | -$2.4M | -$342K | -$900K | -$797K | -$797K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $8.3M | $12.2M | $8.1M | $5.2M | $13M | |
| Selling, General & Admin | $21.5M | $25.1M | $12.6M | $10.7M | $12.8M | |
| Other Inc / (Exp) | $10.2M | $2K | -$98K | $1M | -- | |
| Operating Expenses | $26.7M | $35.1M | $19.8M | $14.8M | $22.2M | |
| Operating Income | -$29.1M | -$35.5M | -$20.7M | -$15.6M | -$23M | |
| Net Interest Expenses | $1.8M | $256K | $112K | $226K | $175K | |
| EBT. Incl. Unusual Items | -$19.9M | -$35.2M | -$20.8M | -$14.2M | -$24.7M | |
| Earnings of Discontinued Ops. | -$8.5M | -$45.9M | -$6.5M | -$5.1M | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$28.4M | -$81.1M | -$27.3M | -$19.3M | -$24.7M | |
| Minority Interest in Earnings | -$4K | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$19.9M | -$35.2M | -$20.8M | -$14.2M | -$24.7M | |
| Basic EPS (Cont. Ops) | -$65.86 | -$1,114.92 | -$26.22 | -$2.70 | -$1.01 | |
| Diluted EPS (Cont. Ops) | -$65.86 | -$1,114.92 | -$26.22 | -$2.70 | -$1.01 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$26M | -$33.3M | -$19.8M | -$14.4M | -$21.9M | |
| EBIT | -$29.1M | -$35.5M | -$20.7M | -$15.6M | -$23M | |
| Revenue (Reported) | $1.3M | $1.8M | $50K | $375K | $300K | |
| Operating Income (Reported) | -$29.1M | -$35.5M | -$20.7M | -$15.6M | -$23M | |
| Operating Income (Adjusted) | -$29.1M | -$35.5M | -$20.7M | -$15.6M | -$23M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $84K | -- | $50K | $200K | $100K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.8M | $793K | $637K | $559K | $530K | |
| Gross Profit | -$1.8M | -$793K | -$587K | -$359K | -$430K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3M | $5.3M | $3.1M | $3.2M | $7.8M | |
| Selling, General & Admin | $9.5M | $12.9M | $6.5M | $5.5M | $7.7M | |
| Other Inc / (Exp) | $5K | -- | -- | -- | -- | |
| Operating Expenses | $10.7M | $17.4M | $9M | $8.2M | $12.5M | |
| Operating Income | -$12.5M | -$18.2M | -$9.6M | -$8.5M | -$12.9M | |
| Net Interest Expenses | $609K | $31K | $60K | $114K | $77K | |
| EBT. Incl. Unusual Items | -$12.4M | -$18.1M | -$9.6M | -$8.4M | -$14.7M | |
| Earnings of Discontinued Ops. | -$8.5M | -$33.6M | -$4.4M | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$20.9M | -$51.7M | -$14M | -$8.4M | -$14.7M | |
| Minority Interest in Earnings | -$1K | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$12.4M | -$18.1M | -$9.6M | -$8.4M | -$14.7M | |
| Basic EPS (Cont. Ops) | -$48.06 | -$109.44 | -$9.22 | -$0.94 | -$0.20 | |
| Diluted EPS (Cont. Ops) | -$47.99 | -$109.44 | -$9.22 | -$0.94 | -$0.20 | |
| Weighted Average Basic Share | $871.8K | $932.5K | $3.1M | $17.8M | $152.1M | |
| Weighted Average Diluted Share | $871.8K | $932.5K | $3.1M | $17.8M | $152.1M | |
| EBITDA | -$10.6M | -$17.4M | -$9M | -$8M | -$12.4M | |
| EBIT | -$12.5M | -$18.2M | -$9.6M | -$8.5M | -$12.9M | |
| Revenue (Reported) | $84K | -- | $50K | $200K | $100K | |
| Operating Income (Reported) | -$12.5M | -$18.2M | -$9.6M | -$8.5M | -$12.9M | |
| Operating Income (Adjusted) | -$12.5M | -$18.2M | -$9.6M | -$8.5M | -$12.9M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $77.4M | $33.5M | $7.3M | $14.2M | $8.6M | |
| Short Term Investments | $19.6M | $10.8M | -- | -- | -- | |
| Accounts Receivable, Net | $426K | $1M | -- | -- | -- | |
| Inventory | $27K | -- | -- | -- | -- | |
| Prepaid Expenses | $2.1M | -- | -- | -- | -- | |
| Other Current Assets | -- | $1.5M | $664K | $749K | -- | |
| Total Current Assets | $104.6M | $45.1M | $26.3M | $15.7M | $9.7M | |
| Property Plant And Equipment | $34.7M | $4.4M | $7.6M | $6.4M | $5.3M | |
| Long-Term Investments | -- | $7.6M | $2M | $1.3M | $1.3M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $952K | $4.9M | $5.4M | $5.4M | -- | |
| Other Long-Term Assets | -- | $43.3M | $253K | $215K | -- | |
| Total Assets | $147M | $99.4M | $41.2M | $28.7M | $23.2M | |
| Accounts Payable | $2.3M | $4.3M | $1.8M | $358K | $2.2M | |
| Accrued Expenses | $2.7M | $3.5M | $414K | $460K | -- | |
| Current Portion Of Long-Term Debt | $600K | -- | -- | $218K | -- | |
| Current Portion Of Capital Lease Obligations | $367K | $91K | $661K | $735K | -- | |
| Other Current Liabilities | -- | $56K | $1.9M | -- | -- | |
| Total Current Liabilities | $6.6M | $30.4M | $21.6M | $3.8M | $6.1M | |
| Long-Term Debt | -- | $3.5M | $3.5M | $3.5M | $2.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $38.4M | $35.9M | $25.8M | $7.4M | $8.3M | |
| Common Stock | $9K | $9K | $20K | $9K | $19K | |
| Other Common Equity Adj | -$63K | -$213K | -- | -- | -- | |
| Common Equity | $108.6M | $63.5M | $15.4M | $21.3M | $14.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$17K | -- | -- | -- | -- | |
| Total Equity | $108.6M | $63.5M | $15.4M | $21.3M | $14.9M | |
| Total Liabilities and Equity | $147M | $99.4M | $41.2M | $28.7M | $23.2M | |
| Cash and Short Terms | $97M | $33.5M | $7.3M | $14.2M | $8.6M | |
| Total Debt | $600K | $3.5M | $3.7M | $3.8M | $3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $57.4M | $9.6M | $3.8M | $7M | $52.7M | |
| Short Term Investments | $18.2M | $5.9M | -- | -- | -- | |
| Accounts Receivable, Net | $111K | $970K | -- | -- | -- | |
| Inventory | $2M | $25K | -- | -- | -- | |
| Prepaid Expenses | $2.9M | -- | -- | -- | -- | |
| Other Current Assets | -- | $414K | $894K | $1.3M | -- | |
| Total Current Assets | $67.5M | $38.2M | $19.7M | $8.3M | $53.4M | |
| Property Plant And Equipment | $38.3M | $7.9M | $6.9M | $5.8M | $5.3M | |
| Long-Term Investments | $14.4M | $253K | $2M | $1.3M | $1.4M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $5M | $5.4M | $5.4M | $6.1M | -- | |
| Other Long-Term Assets | $5.9M | $253K | $215K | $223K | -- | |
| Total Assets | $126.4M | $51.8M | $34M | $21.7M | $64.4M | |
| Accounts Payable | $2.7M | $4M | $1.9M | $614K | $2.7M | |
| Accrued Expenses | $2.8M | $5M | $3.8M | $1.8M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $237K | -- | |
| Current Portion Of Capital Lease Obligations | $205K | $574K | $697K | $667K | -- | |
| Other Current Liabilities | -- | $1.9M | $1.9M | -- | -- | |
| Total Current Liabilities | $8.3M | $27.8M | $21.6M | $4.7M | $5.9M | |
| Long-Term Debt | $27.5M | $3.8M | $3.1M | $3.1M | $1.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $35.9M | $33M | $24.8M | $7.8M | $7.8M | |
| Common Stock | $218K | $12K | $30K | $9K | $30K | |
| Other Common Equity Adj | -$91K | -$167K | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $90.6M | $18.8M | $9.2M | $13.9M | $56.6M | |
| Total Liabilities and Equity | $126.4M | $51.8M | $34M | $21.7M | $64.4M | |
| Cash and Short Terms | $57.4M | $9.6M | $3.8M | $7M | $52.7M | |
| Total Debt | $27.5M | $4.1M | $3.4M | $3.7M | $1.9M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$23.2M | -$50.3M | -$65M | -$24.9M | -$18.4M | |
| Depreciation & Amoritzation | $2.4M | $3.8M | $1.4M | $1.3M | $1.1M | |
| Stock-Based Compensation | $1.6M | $4.4M | $4.4M | $2M | $1.5M | |
| Change in Accounts Receivable | -$10.7M | $4.2M | $6.1M | -- | -- | |
| Change in Inventories | $772K | -$3.9M | -$1M | -- | -- | |
| Cash From Operations | -$30.1M | -$37.8M | -$30.5M | -$18.6M | -$15.3M | |
| Capital Expenditures | $5.2M | $11.6M | $6.4M | $210K | $16K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$26.5M | -$5.1M | $7M | $906K | $742K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $500K | $895K | -- | |
| Long-Term Debt Repaid | -$331K | -$5.8M | -$9.6M | -$2M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $836K | -$372K | -$22K | $116K | -- | |
| Cash From Financing | $78.8M | -$5.8M | $2.3M | $24.5M | $8.9M | |
| Beginning Cash (CF) | $55.1M | $22.7M | $7.3M | $14.2M | $8.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $22.3M | -$48.7M | -$21.1M | $6.8M | -$5.6M | |
| Ending Cash (CF) | $77.4M | -$26.1M | -$13.7M | $21.1M | $2.9M | |
| Levered Free Cash Flow | -$35.2M | -$49.4M | -$36.9M | -$18.8M | -$15.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11.9M | -$33.6M | -$8.2M | -$4.4M | -$9M | |
| Depreciation & Amoritzation | $1M | $299K | $319K | $281K | $241K | |
| Stock-Based Compensation | $1.1M | $1.1M | $456K | $475K | $253K | |
| Change in Accounts Receivable | $96K | $85K | -- | -- | -- | |
| Change in Inventories | -$1.4M | $79K | -- | -- | -- | |
| Cash From Operations | -$10.7M | -$7.6M | -$4.7M | -$3.9M | -$5.2M | |
| Capital Expenditures | $2.1M | $3M | -- | $1K | $516K | |
| Cash Acquisitions | $50K | -- | -- | -- | -- | |
| Cash From Investing | -$1M | -$1.3M | -- | -$2K | -$3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $500K | -- | -- | -- | |
| Long-Term Debt Repaid | -$5.7M | -$6.3M | -$107K | -$170K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$372K | -$22K | -- | -- | -- | |
| Cash From Financing | -$6M | -$3M | $4M | -$152K | $8.8M | |
| Beginning Cash (CF) | $39.2M | $3.7M | $3.8M | $7M | $28.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$17.7M | -$11.9M | -$701K | -$4M | $561K | |
| Ending Cash (CF) | $21.5M | -$8.2M | $3.1M | $3M | $29.2M | |
| Levered Free Cash Flow | -$12.8M | -$10.6M | -$4.7M | -$3.9M | -$5.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$28.4M | -$81.1M | -$27.3M | -$19.3M | -$24.7M | |
| Depreciation & Amoritzation | $3.1M | $2.7M | $1.2M | $1.2M | $1.1M | |
| Stock-Based Compensation | $2.9M | $4.8M | $3.3M | $1.7M | $1.2M | |
| Change in Accounts Receivable | -$10.6M | $4.2M | $6.1M | -- | -- | |
| Change in Inventories | -$914K | -$3M | $43K | -- | -- | |
| Cash From Operations | -$34.6M | -$39.4M | -$18.9M | -$16.1M | -$18.6M | |
| Capital Expenditures | $9.7M | $11.6M | $305K | $211K | $563K | |
| Cash Acquisitions | $50K | -$50K | -- | -- | -- | |
| Cash From Investing | -$13.1M | -$182K | $8.3M | $1.6M | -$24.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$6M | -$6.4M | -$3.9M | -$1.7M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $204K | -- | -- | |
| Cash From Financing | $1.6M | -$1.7M | $10.7M | $17.7M | $64.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$46.1M | -$41.2M | $111K | $3.2M | $21.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$44.3M | -$51M | -$19.2M | -$16.3M | -$19.2M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$20.9M | -$51.7M | -$14M | -$8.4M | -$14.7M | |
| Depreciation & Amoritzation | $1.8M | $793K | $637K | $559K | $530K | |
| Stock-Based Compensation | $1.9M | $2.3M | $1.2M | $890K | $576K | |
| Change in Accounts Receivable | $3K | $31K | -- | -- | -$65K | |
| Change in Inventories | -$2M | -$1.1M | -- | -- | -- | |
| Cash From Operations | -$20M | -$21.6M | -$10M | -$7.6M | -$10.9M | |
| Capital Expenditures | $6.1M | $6.1M | -- | $1K | $548K | |
| Cash Acquisitions | $50K | -- | -- | -- | -- | |
| Cash From Investing | -$6.2M | -$1.2M | $50K | $711K | -$24.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $500K | -- | -- | -- | |
| Long-Term Debt Repaid | -$5.8M | -$6.4M | -$647K | -$336K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$372K | -$22K | $204K | -- | -- | |
| Cash From Financing | -$6.1M | -$1.9M | $6.5M | -$314K | $55.5M | |
| Beginning Cash (CF) | $102M | $13.6M | $8.4M | $18.1M | $56.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$32.3M | -$24.7M | -$3.5M | -$7.2M | $20.1M | |
| Ending Cash (CF) | $69.8M | -$11.1M | $4.8M | $10.9M | $76.9M | |
| Levered Free Cash Flow | -$26.2M | -$27.7M | -$10M | -$7.6M | -$11.5M | |
Get IBIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IBIO
Sector
P/E ratio
--
22.85x
PEG ratio
--
-0.01x
P/B ratio
1.73x
1.78x
Price / LTM sales
420.73x
1.52x
Growth Metrics
IBIO
Sector
Revenue growth
-100%
3.33%
Earnings growth
81.02%
11.64%
Revenue (5-year growth)
-24.57%
6.41%
Earnings forecast
-$0.07
-$0.20
Profitability
IBIO
Sector
Profitability FY 2025
-$726K
$2.3M
Return on invested capital
-72.75%
-33.31%
Return on assets
-64.24%
-29.79%
Return on equity
-80.97%
-38.98%
Earnings Date
Last Earnings Date
May
15
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Jun
4
Balance Sheet
IBIO
Sector
Total cash
$52.7M
$24.1M
Short term investments
--
$23.8M
Total assets
$23.2M
$70.1M
Long term debt
$1.9M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
93
NBTX alert for Mar 5
Nanobiotix SA [NBTX] is up 17.92% over the past day.
Sell
45
MRNA alert for Mar 5
Moderna, Inc. [MRNA] is up 16.05% over the past day.
Buy
77
SSRM alert for Mar 5
SSR Mining, Inc. [SSRM] is up 14.97% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
